Roche Halts Development of Drug Candidate for Muscle Diseases, Chugai Says

Core Viewpoint - The company has decided to discontinue the development of emugrobart after two studies indicated that the drug did not meet its intended outcomes [1] Group 1 - The decision to halt emugrobart's development was influenced by the results of two studies [1]